Final Report for the 108th Congress, 2004

CLINICAL TRIALS ACCESS

H. R. 2021- Access to Cancer Clinical Trials Act of 2003

• Introduced by Representative Deborah Pryce (R-OH) on May 7, 2003 and referred to the House Committee on Ways and Means, House Committee on Education and the Workforce and House Committee on Energy and Commerce
• A bill to amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code of 1986 to require group and individual health plans to provide coverage for individuals participating in approved cancer clinical trials
• Status: Since this bill was not acted upon before the 108th Congress adjourned, the measure died. In order to be considered again, it would need to be reintroduced in the 109th Congress

S. 2083 - Bipartisan Patient Protection Act of 2004

• Introduced by Senator Barbara Boxer (D-CA) on February 12, 2004 and referred to the Senate Committee on Health, Education, Labor, and Pensions
• A bill which would require health care insurers to allow their enrollees to participate in clinical trials
• Status: Since this bill was not acted upon before the 108th Congress adjourned, the measure died. In order to be considered again, it would need to be reintroduced in the 109th Congress

Previous Page | Index | Next Page

Home Page | Committees | Hearings and Testimony | Legislative History | Legislative Update
Hot Topics and More Information | How to Reach Us

This site is provided as an informational service for advisory committee members, patient groups, members of the public, and employees, and does not constitute the endorsement of the NCI, NIH, or DHHS of any legislative proposal. No inference should be drawn from the coverage or lack of coverage of any pending legislation herein.